Denise M Bruno1, Tracey E Wilson2, Francesca Gany3, Abraham Aragones4. 1. Department of Community Health Sciences, State University of New York, Downstate Medical Center, School of Public Health, 450 Clarkson Avenue, Mail Stop Code 43, Brooklyn, NY 11203, USA. Electronic address: denise.bruno@downstate.edu. 2. Department of Community Health Sciences, State University of New York, Downstate Medical Center, School of Public Health, 450 Clarkson Avenue, Mail Stop Code 43, Brooklyn, NY 11203, USA. Electronic address: tracey.wilson@downstate.edu. 3. Immigrant Health and Cancer Disparities, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA. Electronic address: ganyf@mskcc.org. 4. Immigrant Health and Cancer Disparities, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA. Electronic address: aragonea@mskcc.org.
Abstract
OBJECTIVE: Minority populations in the United States are disproportionally affected by human papillomavirus (HPV) infection and HPV-related cancer. We sought to understand physician practices, knowledge and beliefs that affect utilization of the HPV vaccine in primary care settings serving large minority populations in areas with increased rates of HPV-related cancer. STUDY DESIGN: Cross-sectional survey of randomly selected primary care providers, including pediatricians, family practice physicians and internists, serving large minority populations in Brooklyn, N.Y. and in areas with higher than average cervical cancer rates. RESULTS: Of 156 physicians randomly selected, 121 eligible providers responded to the survey; 64% were pediatricians, 19% were internists and 17% were family practitioners. Thirty-four percent of respondents reported that they routinely offered HPV vaccine to their eligible patients. Seventy percent of physicians reported that the lack of preventive care visits for patients in the eligible age group limited their ability to recommend the HPV vaccine and 70% of those who reported this barrier do not routinely recommend HPV vaccine. The lack of time to educate parents about the HPV vaccine and cost of the vaccine to their patients were two commonly reported barriers that affected whether providers offered the vaccine. CONCLUSIONS: Our study found that the majority of providers serving the highest risk populations for HPV infection and HPV-related cancers are not routinely recommending the HPV vaccine to their patients. Reasons for providers' failure to recommend the HPV vaccine routinely are identified and possible areas for targeted interventions to increase HPV vaccination rates are discussed.
OBJECTIVE: Minority populations in the United States are disproportionally affected by human papillomavirus (HPV) infection and HPV-related cancer. We sought to understand physician practices, knowledge and beliefs that affect utilization of the HPV vaccine in primary care settings serving large minority populations in areas with increased rates of HPV-related cancer. STUDY DESIGN: Cross-sectional survey of randomly selected primary care providers, including pediatricians, family practice physicians and internists, serving large minority populations in Brooklyn, N.Y. and in areas with higher than average cervical cancer rates. RESULTS: Of 156 physicians randomly selected, 121 eligible providers responded to the survey; 64% were pediatricians, 19% were internists and 17% were family practitioners. Thirty-four percent of respondents reported that they routinely offered HPV vaccine to their eligible patients. Seventy percent of physicians reported that the lack of preventive care visits for patients in the eligible age group limited their ability to recommend the HPV vaccine and 70% of those who reported this barrier do not routinely recommend HPV vaccine. The lack of time to educate parents about the HPV vaccine and cost of the vaccine to their patients were two commonly reported barriers that affected whether providers offered the vaccine. CONCLUSIONS: Our study found that the majority of providers serving the highest risk populations for HPV infection and HPV-related cancers are not routinely recommending the HPV vaccine to their patients. Reasons for providers' failure to recommend the HPV vaccine routinely are identified and possible areas for targeted interventions to increase HPV vaccination rates are discussed.
Authors: Susan T Vadaparampil; Teri L Malo; Jessica A Kahn; Daniel A Salmon; Ji-Hyun Lee; Gwendolyn P Quinn; Richard G Roetzheim; Karen L Bruder; Tina M Proveaux; Xiuhua Zhao; Neal A Halsey; Anna R Giuliano Journal: Am J Prev Med Date: 2014-01 Impact factor: 5.043
Authors: Susan T Vadaparampil; Stephanie A S Staras; Teri L Malo; Katie Z Eddleton; Juliette Christie; Maria Rodriguez; Anna R Giuliano; Elizabeth A Shenkman Journal: Cancer Date: 2012-08-01 Impact factor: 6.860
Authors: Natalie Pierre Joseph; Jack A Clark; Howard Bauchner; Jared P Walsh; Glory Mercilus; Jean Figaro; Caroline Bibbo; Rebecca B Perkins Journal: Womens Health Issues Date: 2012 Nov-Dec
Authors: Djin Lai; Julia Bodson; France A Davis; Doriena Lee; Fahina Tavake-Pasi; Edwin Napia; Jeannette Villalta; Valentine Mukundente; Ryan Mooney; Heather Coulter; Louisa A Stark; Ana C Sanchez-Birkhead; Deanna Kepka Journal: J Community Health Date: 2017-04
Authors: M Killian; M Detoc; P Berthelot; R Charles; A Gagneux-Brunon; F Lucht; C Pulcini; S Barbois; E Botelho-Nevers Journal: Eur J Clin Microbiol Infect Dis Date: 2016-08-03 Impact factor: 3.267
Authors: Albert J Farias; Lara S Savas; Maria E Fernandez; Sharon P Coan; Ross Shegog; C Mary Healy; Erica Lipizzi; Sally W Vernon Journal: Prev Med Date: 2017-08-20 Impact factor: 4.018
Authors: Stephanie A Irving; Holly C Groom; Shannon Stokley; Michael M McNeil; Julianne Gee; Ning Smith; Allison L Naleway Journal: Acad Pediatr Date: 2018-03 Impact factor: 3.107
Authors: Lisa N Mansfield; Elijah O Onsomu; Elizabeth Merwin; Naomi M Hall; Alfreda Harper-Harrison Journal: West J Nurs Res Date: 2016-12-01 Impact factor: 1.967
Authors: Laura A Shay; Austin S Baldwin; Andrea C Betts; Emily G Marks; Robin T Higashi; Richard L Street; Donna Persaud; Jasmin A Tiro Journal: Pediatrics Date: 2018-05-15 Impact factor: 7.124